Liquid Phase Peptide Synthesis Market Share

  • Report ID: 3221
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Liquid Phase Peptide Synthesis Market Share

North American Market Forecast

North America liquid phase peptide synthesis market is estimated to account for 42% of the revenue share by 2036. The North American market stands as a prominent hub in the global landscape due to several key factors. Fueled by robust research and development activities, the region witnesses extensive utilization of peptides in drug discovery and development by pharmaceutical giants and biotechnology firms. In 2021, research and development expenditure in the United States pharmaceuticals industry amounted to around USD 102 billion. With a strong presence of cutting-edge technology and state-of-the-art infrastructure, North America showcases a significant market share in Liquid Phase Peptide Synthesis.

APAC Market Statistics

Asia Pacific region is also poised to garner significant revenue share, the Asia Pacific liquid phase peptide synthesis market is experiencing substantial growth attributed to several key factors. Rapid economic development, coupled with increasing healthcare expenditure across countries like China, India, Japan, South Korea, and others, is driving the market’s expansion. The region’s pharmaceutical industry is witnessing remarkable advancements, fostering a conducive environment for peptide synthesis technologies. Additionally, the escalating prevalence of chronic diseases and the growing demand for innovative therapeutic solutions fuel the adoption of liquid-phase peptide synthesis in drug discovery and development within the Asia Pacific.

Research Nester
Liquid Phase Peptide Synthesis Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3221
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing demand for peptide-based therapeutics, expanding applications, research and development, and supportive government policies are some of the major growth factors for the market’s growth.

The market size of liquid phase peptide synthesis is anticipated to attain a CAGR of 10 % over the forecast period, i.e., 2024-2036.

The major players in the market are CEM Corporation, Bachem AG, CSBio, Biotage, AnaSpec, ZenBio, Inc., Thermo Fisher Scientific Inc., GenScript, PolyPeptide Group, Sosei Group Corporation, Tokyo Mirai Style Co., Ltd., and others.

The Therapeutics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample